Beneficial effects of Panax ginseng for the treatment and prevention of neurodegenerative diseases: past findings and future directions

In recent years, several therapeutic drugs have been rationally designed and synthesized based on the novel knowledge gained from investigating the actions of biologically active chemicals derived from foods, plants, and medicinal herbs. One of the major advantages of these naturalistic chemicals is their ability to interact with multiple targets in the body resulting in a combined beneficial effect. Ginseng is a perennial herb (Araliaceae family), a species within the genus Panax, and a highly valued and popular medicinal plant. Evidence for the medicinal and health benefits of Panax ginseng and its components in preventing neurodegeneration has increased significantly in the past decade. The beneficial effects of P. ginseng on neurodegenerative diseases have been attributed primarily to the antioxidative and immunomodulatory activities of its ginsenoside components. Mechanistic studies on the neuroprotective effects of ginsenosides revealed that they act not only as antioxidants but also as modulators of intracellular neuronal signaling and metabolism, cell survival/death genes, and mitochondrial function. The goal of the present paper is to provide a brief review of recent knowledge and developments concerning the beneficial effects as well as the mechanism of action of P. ginseng and its components in the treatment and prevention of neurodegenerative diseases.

[1]  Joseph B. Martin Huntington's disease , 1984, Neurology.

[2]  L. Xiong,et al.  Ginsenoside Rd attenuates early oxidative damage and sequential inflammatory response after transient focal ischemia in rats , 2011, Neurochemistry International.

[3]  D. Butterfield,et al.  Ischemia/reperfusion-induced changes in membrane proteins and lipids of gerbil cortical synaptosomes , 1995, Neuroscience.

[4]  N. Fuzzati Analysis methods of ginsenosides. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[5]  X. Jia,et al.  Ginsenoside Rg5 improves cognitive dysfunction and beta-amyloid deposition in STZ-induced memory impaired rats via attenuating neuroinflammatory responses. , 2014, International immunopharmacology.

[6]  Y. Ihara,et al.  Lewy bodies are ubiquitinated , 1988, Acta Neuropathologica.

[7]  C. Marsden,et al.  Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's Disease , 1989, Journal of neurochemistry.

[8]  L. Xiong,et al.  Ginsenoside Rd promotes glutamate clearance by up-regulating glial glutamate transporter GLT-1 via PI3K/AKT and ERK1/2 pathways , 2013, Front. Pharmacol..

[9]  Dong-Hyun Kim Chemical Diversity of Panax ginseng, Panax quinquifolium, and Panax notoginseng , 2012, Journal of ginseng research.

[10]  G. Zhao,et al.  Ginsenoside Rd attenuates mitochondrial dysfunction and sequential apoptosis after transient focal ischemia , 2011, Neuroscience.

[11]  D. Dickson,et al.  Pathology and Biology of the Lewy Body , 1993, Journal of neuropathology and experimental neurology.

[12]  A. Lees,et al.  A Generalised Increase in Protein Carbonyls in the Brain in Parkinson's but Not Incidental Lewy Body Disease , 1997, Journal of neurochemistry.

[13]  Shao Li,et al.  Neuroprotective effects of ginsenoside Rg1 through the Wnt/β-catenin signaling pathway in both in vivo and in vitro models of Parkinson's disease , 2016, Neuropharmacology.

[14]  X. Jia,et al.  Ginseng improves cognitive deficit via the RAGE/NF-κB pathway in advanced glycation end product-induced rats , 2014, Journal of ginseng research.

[15]  B. Hyman,et al.  Neuropathological alterations in Alzheimer disease. , 2011, Cold Spring Harbor perspectives in medicine.

[16]  K. Lange,et al.  Pathogenesis of Parkinson's disease. , 1992, Current opinion in neurology and neurosurgery.

[17]  Q. Li,et al.  Long-term ginsenoside administration prevents memory loss in aged female C57BL/6J mice by modulating the redox status and up-regulating the plasticity-related proteins in hippocampus , 2011, Neuroscience.

[18]  박종대 고려인삼의 화학성분에 관한 고찰 ( Recent Studies on the Chemical Constituents of Korean Ginseng ) , 1996 .

[19]  B. Zhu CNS dopamine oxidation and catechol-O-methyltransferase: importance in the etiology, pharmacotherapy, and dietary prevention of Parkinson's disease. , 2004, International journal of molecular medicine.

[20]  T. Sakata,et al.  Central Effects of Ginsenosides on the Feeding Behavior and Response to Stress in Rats , 1987 .

[21]  Yifa Zhou,et al.  Total fractionation and characterization of the water-soluble polysaccharides isolated from Panax ginseng C. A. Meyer. , 2009 .

[22]  D. Butterfield,et al.  Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer’s disease brain contribute to neuronal death , 2002, Neurobiology of Aging.

[23]  Hairong Cheng,et al.  Anti-fatigue activity of the water-soluble polysaccharides isolated from Panax ginseng C. A. Meyer. , 2010, Journal of ethnopharmacology.

[24]  Jin Sun,et al.  Ginseng for Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. , 2015, Current topics in medicinal chemistry.

[25]  Hee-Young Yang,et al.  Antioxidant enzymes as redox-based biomarkers: a brief review , 2015, BMB reports.

[26]  S. Kwon,et al.  Ginsenosides protect striatal neurons in a cellular model of Huntington's disease , 2009, Journal of neuroscience research.

[27]  O. Tanaka,et al.  STUDIES ON THE CONSTITUENTS OF JAPANESE AND CHINESE CRUDE DRUGS. XI. PANAXADIOL, A SAPOGENIN OF GINSENG ROOTS. , 1963, Chemical & pharmaceutical bulletin.

[28]  M. Yoshikura,et al.  [Studies on the components of Panax ginseng C.A. Meyer. V. On the structure of a new acetylene derivative "Panaxynol" (3). Synthesis of 1,9-(cis)-heptadecadiene-4,6-diyn-3-ol]. , 1966, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

[29]  Hairong Cheng,et al.  The inhibitory effect of ginseng pectin on L-929 cell migration , 2010, Archives of pharmacal research.

[30]  Yan Liu,et al.  Ginsenoside Rg1 attenuates okadaic acid induced spatial memory impairment by the GSK3β/tau signaling pathway and the Aβ formation prevention in rats. , 2013, European journal of pharmacology.

[31]  E. Ling,et al.  Protective effects of ginseng on neurological disorders , 2015, Front. Aging Neurosci..

[32]  S. Y. Choi,et al.  Epidemiological study on cancer prevention by ginseng: are all kinds of cancers preventable by ginseng? , 2001, Journal of Korean medical science.

[33]  J. Andersen,et al.  Oxidative stress in neurodegeneration: cause or consequence? , 2004, Nature Reviews Neuroscience.

[34]  B. Marchetti,et al.  To be or not to be (inflamed)--is that the question in anti-inflammatory drug therapy of neurodegenerative disorders? , 2005, Trends in pharmacological sciences.

[35]  S. Helms Cancer prevention and therapeutics: Panax ginseng. , 2004, Alternative medicine review : a journal of clinical therapeutic.

[36]  Hyeyoung Min,et al.  Ginseng, the 'Immunity Boost': The Effects of Panax ginseng on Immune System , 2012, Journal of ginseng research.

[37]  Elena Cattaneo,et al.  Molecular mechanisms and potential therapeutical targets in Huntington's disease. , 2010, Physiological reviews.

[38]  H. Zhai,et al.  Effects of Ginsenoside Rg1 on the Expression of Toll-Like Receptor 3, 4 and Their Signalling Transduction Factors in the NG108-15 Murine Neuroglial Cell Line , 2014, Molecules.

[39]  Y. Liu,et al.  A UPLC/MS-based metabolomics investigation of the protective effect of ginsenosides Rg1 and Rg2 in mice with Alzheimer's disease , 2015, Journal of ginseng research.

[40]  O. Hornykiewicz Dopamine in the basal ganglia. Its role and therapeutic implications (including the clinical use of L-DOPA). , 1973, British medical bulletin.

[41]  Yong Li,et al.  Long-term ginsenoside consumption prevents memory loss in aged SAMP8 mice by decreasing oxidative stress and up-regulating the plasticity-related proteins in hippocampus , 2009, Brain Research.

[42]  H. Iwabuchi,et al.  Studies on the sesquiterpenoids of Panax ginseng C. A. Meyer. II. Isolation and structure determination of ginsenol, a novel sesquiterpene alcohol. , 1988, Chemical & pharmaceutical bulletin.

[43]  M. Bajda,et al.  Multi-target-directed ligands in Alzheimer's disease treatment. , 2011, Current medicinal chemistry.

[44]  Hyeon-Joong Kim,et al.  Hippocampus-dependent cognitive enhancement induced by systemic gintonin administration , 2015, Journal of ginseng research.

[45]  C. Sung,et al.  Long-term administration of ginsenoside Rh1 enhances learning and memory by promoting cell survival in the mouse hippocampus. , 2014, International journal of molecular medicine.

[46]  R. Dempsey,et al.  Phospholipase A2, hydroxyl radicals, and lipid peroxidation in transient cerebral ischemia. , 2003, Antioxidants & redox signaling.

[47]  Jianming Lü,et al.  Ginseng compounds: an update on their molecular mechanisms and medical applications. , 2009, Current vascular pharmacology.

[48]  G. Wilcock,et al.  The cholinergic hypothesis of Alzheimer’s disease: a review of progress , 1999, Journal of neurology, neurosurgery, and psychiatry.

[49]  Y. Oshima,et al.  Isolation and Hypoglycemic Activity of Panaxans F, G and H, Glycans of Panax ginseng Roots , 1985 .

[50]  Zhiqiang Liu,et al.  Ginsenosides attenuate d-galactose- and AlCl3-inducedspatial memory impairment by restoring the dysfunction of the neurotransmitter systems in the rat model of Alzheimer's disease. , 2016, Journal of ethnopharmacology.

[51]  Lei Zheng,et al.  Neuroprotective effects of pretreatment of ginsenoside Rb1 on severe cerebral ischemia‐induced injuries in aged mice: Involvement of anti‐oxidant signaling , 2017, Geriatrics & gerontology international.

[52]  K. Kang,et al.  Increase in apoptotic effect of Panax ginseng by microwave processing in human prostate cancer cells: in vitro and in vivo studies , 2015, Journal of ginseng research.

[53]  H. Cho,et al.  Effects of wild ginseng (Panax ginseng C.A. Meyer) leaves on lipid peroxidation levels and antioxidant enzyme activities in streptozotocin diabetic rats. , 2005, Journal of ethnopharmacology.

[54]  Khaled Radad,et al.  Ginsenosides and Their CNS Targets , 2011, CNS neuroscience & therapeutics.

[55]  S. Pyo,et al.  Korean Red Ginseng inhibits apoptosis in neuroblastoma cells via estrogen receptor β-mediated phosphatidylinositol-3 kinase/Akt signaling , 2014, Journal of ginseng research.

[56]  C. Yuan,et al.  Ginseng and diabetes. , 2005, The American journal of Chinese medicine.

[57]  J. Son,et al.  Neuronal autophagy and neurodegenerative diseases , 2012, Experimental & Molecular Medicine.

[58]  T. Yasuda,et al.  Ginseng extract scavenges hydroxyl radical and protects unsaturated fatty acids from decomposition caused by iron-mediated lipid peroxidation. , 1996, Free radical biology & medicine.

[59]  T. Sakata,et al.  Attenuation of anorexia induced by heat or surgery during sustained administration of ginsenoside Rg1 into rat third ventricle , 2004, Psychopharmacology.

[60]  M. Gurney,et al.  Increased 3‐nitrotyrosine and oxidative damage in mice with a human copper/zinc superoxide dismutase mutation , 1997, Annals of neurology.

[61]  S. Humbert,et al.  The Biology of Huntingtin , 2016, Neuron.

[62]  Yong Tae Kwon,et al.  Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies , 2015, Experimental & Molecular Medicine.

[63]  K. Kang,et al.  Beneficial effects of fermented black ginseng and its ginsenoside 20(S)-Rg3 against cisplatin-induced nephrotoxicity in LLC-PK1 cells , 2015, Journal of ginseng research.

[64]  이영철,et al.  인삼에 함유된 페놀성 성분의 신경세포보호 및 항염증 효과 , 2009 .

[65]  Marios Politis,et al.  Hypothalamic involvement in Huntington's disease: an in vivo PET study. , 2008, Brain : a journal of neurology.

[66]  K. Chu,et al.  Heat-processed ginseng enhances the cognitive function in patients with moderately severe Alzheimer's disease , 2012, Nutritional neuroscience.

[67]  D. Holtzman,et al.  Sleep, circadian rhythms, and the pathogenesis of Alzheimer Disease , 2015, Experimental & Molecular Medicine.

[68]  N. Chen,et al.  Protopanaxtriol protects against 3-nitropropionic acid-induced oxidative stress in a rat model of Huntington's disease , 2015, Acta Pharmacologica Sinica.

[69]  O. Hornykiewicz How L-DOPA was discovered as a drug for Parkinson's disease 40 years ago. , 2001, Wiener klinische Wochenschrift.

[70]  D. Rhee,et al.  Biological Activities and Chemistry of Saponins from Panax ginseng C. A. Meyer , 2005, Phytochemistry Reviews.

[71]  Hwan-Suck Chung,et al.  Bee venom phospholipase A2 ameliorates motor dysfunction and modulates microglia activation in Parkinson's disease alpha-synuclein transgenic mice , 2016, Experimental & Molecular Medicine.

[72]  S. Fahn,et al.  Should Levodopa Therapy for Parkinsonism be Started Early or Late? Evidence Against Early Treatment , 1984, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[73]  Sung-Chun Tang,et al.  Pathophysiology, treatment, and animal and cellular models of human ischemic stroke , 2011, Molecular Neurodegeneration.

[74]  B. D. Lee,et al.  Function and dysfunction of leucine-rich repeat kinase 2 (LRRK2): Parkinson’s disease and beyond , 2015, BMB reports.

[75]  Seung-Hyun Kim,et al.  Comparative phenolic compound profiles and antioxidative activity of the fruit, leaves, and roots of Korean ginseng (Panax ginseng Meyer) according to cultivation years , 2015, Journal of ginseng research.

[76]  E. González-Burgos,et al.  Potential Neuroprotective Activity of Ginseng in Parkinson’s Disease: A Review , 2014, Journal of Neuroimmune Pharmacology.

[77]  Linfu Zhou,et al.  Ginsenoside-Rd attenuates TRPM7 and ASIC1a but promotes ASIC2a expression in rats after focal cerebral ischemia , 2012, Neurological Sciences.

[78]  M. Won,et al.  Immunohistochemical detection of oxidative DNA damage induced by ischemia–reperfusion insults in gerbil hippocampus in vivo , 1999, Brain Research.

[79]  F. Walker Huntington's disease , 2007, The Lancet.

[80]  D. Butterfield,et al.  Natural antioxidants in Alzheimer's disease , 2007, Expert opinion on investigational drugs.

[81]  W. König,et al.  Three sesquiterpene hydrocarbons from the roots of Panax ginseng C.A. Meyer (Araliaceae). , 2005, Phytochemistry.

[82]  M. Muenter,et al.  Multi‐center study of Parkinson mortality with early versus later dopa treatment , 1987, Annals of neurology.

[83]  S. Fahn,et al.  The oxidant stress hypothesis in Parkinson's disease: Evidence supporting it , 1992, Annals of neurology.

[84]  K. Takada,et al.  Characterization of two acidic polysaccharides having immunological activities from the root of Panax ginseng. , 1993, Biological & pharmaceutical bulletin.

[85]  S. Joo,et al.  Reciprocal Activity of Ginsenosides in the Production of Proinflammatory Repertoire, and their Potential Roles in Neuroprotection in vitro , 2005, Planta medica.

[86]  B. Aggarwal,et al.  Neuroprotection by Spice-Derived Nutraceuticals: You Are What You Eat! , 2011, Molecular Neurobiology.

[87]  Yifa Zhou,et al.  Neuroprotective effects of ginseng pectin through the activation of ERK/MAPK and Akt survival signaling pathways. , 2012, Molecular medicine reports.

[88]  Y. Mizuno,et al.  Parkinson's disease: from etiology to treatment. , 1995, Internal medicine.

[89]  Yifan Han,et al.  Protection against 1-methyl-4-phenylpyridinium ion (MPP+)-induced apoptosis by water extract of ginseng (Panax ginseng C.A. Meyer) in SH-SY5Y cells. , 2011, Journal of ethnopharmacology.

[90]  Y. Oshima,et al.  Isolation and hypoglycemic activity of panaxans Q, R, S, T and U, glycans of Panax ginseng roots. , 1985, Journal of ethnopharmacology.

[91]  W. Markesbery,et al.  Electrochemical Analysis of Protein Nitrotyrosine and Dityrosine in the Alzheimer Brain Indicates Region-Specific Accumulation , 1998, The Journal of Neuroscience.

[92]  H. Baik,et al.  CB2 receptor activation prevents glial-derived neurotoxic mediator production, BBB leakage and peripheral immune cell infiltration and rescues dopamine neurons in the MPTP model of Parkinson's disease , 2016, Experimental & Molecular Medicine.

[93]  H. Iwabuchi,et al.  Studies on the sesquiterpenoids of Panax ginseng C. A. Meyer. IV. , 1990, Chemical & pharmaceutical bulletin.

[94]  Dong Zhou,et al.  Radix/rhizoma notoginseng extract (sanchitongtshu) for ischemic stroke: a randomized controlled study. , 2011, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[95]  S. Kwon,et al.  Chemical diversity of ginseng saponins from Panax ginseng☆ , 2015, Journal of ginseng research.

[96]  L. B. Babiker,et al.  INVESTIGATION OF STABILITY OF KOREAN GINSENG IN HERBAL DRUG PRODUCT , 2014 .

[97]  Z. Dong,et al.  Ginsenoside Rd Protects SH-SY5Y Cells against 1-Methyl-4-phenylpyridinium Induced Injury , 2015, International journal of molecular sciences.

[98]  Sang Myung Lee,et al.  Characterization of Korean Red Ginseng (Panax ginseng Meyer): History, preparation method, and chemical composition , 2015, Journal of ginseng research.

[99]  K. Sugiyama,et al.  Isolation and hypoglycaemic activity of panaxans A, B, C, D and E, glycans of Panax ginseng roots. , 1984, Planta medica.

[100]  Dong-Hyun Kim,et al.  Ginsenosides Rg5 and Rh3 protect scopolamine-induced memory deficits in mice. , 2013, Journal of ethnopharmacology.

[101]  J. Parodi,et al.  Amyloid pore-channel hypothesis: effect of ethanol on aggregation state using frog oocytes for an Alzheimer’s disease study , 2015, BMB reports.

[102]  J-Y Wang,et al.  Ginsenine, a new alkaloid from the berry of Panax ginseng C. A. Meyer , 2006, Journal of Asian natural products research.

[103]  M. Nagai,et al.  STUDIES ON THE CONSTITUENTS OF JAPANESE AND CHINESE CRUDE DRUGS. XII. PANAXADIOL, A SAPOGENIN OF GINSENG ROOTS. , 1963, Chemical & pharmaceutical bulletin.

[104]  A. Rosenblatt Neuropsychiatry of Huntington's disease , 2007, Dialogues in clinical neuroscience.

[105]  Yadong Huang,et al.  Stem cell therapy for Alzheimer's disease and related disorders: current status and future perspectives , 2015, Experimental & Molecular Medicine.

[106]  H. Heinsen,et al.  The Neuropathology of Huntington’s Disease: Classical Findings, Recent Developments and Correlation to Functional Neuroanatomy , 2015, Advances in Anatomy, Embryology and Cell Biology.

[107]  P. Xiao,et al.  Recent advances on ginseng research in China. , 1992, Journal of ethnopharmacology.

[108]  S. Yim,et al.  Proteomic analysis reveals that the protective effects of ginsenoside Rb1 are associated with the actin cytoskeleton in β-amyloid-treated neuronal cells , 2015, Journal of ginseng research.

[109]  I. Cho Effects of Panax ginseng in Neurodegenerative Diseases , 2012, Journal of ginseng research.

[110]  D. Baker,et al.  Inflammation in neurodegenerative diseases , 2010, Immunology.

[111]  Dongsun Park,et al.  Suppressive effects of red ginseng preparations on SW480 colon cancer xenografts in mice , 2011 .

[112]  K. Kang,et al.  Heat-processed Panax ginseng and diabetic renal damage: active components and action mechanism , 2013, Journal of ginseng research.